Chris Evert Says Ovarian Cancer Returned for 3rd Time, Missing Wimbledon
Updated
Updated · CNN · Jun 25
Chris Evert Says Ovarian Cancer Returned for 3rd Time, Missing Wimbledon
3 articles · Updated · CNN · Jun 25
Summary
Chris Evert, 71, said her ovarian cancer has returned again, forcing her to miss Wimbledon and step back from professional work for the next few months.
Surgery has already been completed as the first step in treatment, and the 18-time Grand Slam singles champion said chemotherapy will begin in the coming weeks.
Evert was first diagnosed in December 2021 and disclosed another recurrence in December 2023, making this the third time she has faced the disease.
The ESPN analyst said she remains optimistic and determined, calling ovarian cancer "relentless" and thanking her medical team, family and supporters.
Chris Evert's BRCA1 gene was a crucial warning. Can new therapies finally conquer these relentless hereditary cancers?
After beating cancer twice, what makes chemo-resistant ovarian cancer so difficult to defeat for good?
From Grand Slam Champions to Cancer Advocates: The Evert-Navratilova Story
Overview
Chris Evert, the legendary tennis champion, has faced multiple battles with ovarian cancer since her first diagnosis in December 2021. After completing chemotherapy in 2022 and overcoming a recurrence in 2023, she experienced another health setback in June 2026 when an abnormal CT scan suggested a new recurrence. This led to exploratory surgery and further chemotherapy, causing her to miss Wimbledon 2026. Evert’s journey highlights her resilience and ongoing commitment to advocacy, as she continues to inspire others by sharing her experiences and prioritizing her health and family.